CP-25, a Novel Anti-inflammatory and Immunomodulatory Drug, Inhibits the Functions of Activated Human B Cells through Regulating BAFF and TNF-alpha Signaling and Comparative Efficacy with Biological Agents

• Główni autorzy: Feng Zhang (Autor), Jin-Ling Shu (Autor), Ying Li (Autor), Yu-Jing Wu (Autor), Xian-Zheng Zhang (Autor), Le Han (Autor), Xiao-Yu Tang (Autor), Chen Wang (Autor), Qing-Tong Wang (Autor), Jing-Yu Chen (Autor), Yan Chang (Autor), Hua-Xun Wu (Autor), Ling-Ling Zhang (Autor), Wei Wei (Autor)
• Format: Książka
• Wydane: Frontiers Media S.A., 2017-12-01T00:00:00Z.
• Hasła przedmiotowe: article
• Dostęp online: Connect to this object online.

Paeoniflorin-6'-O-benzene sulfonate (code: CP-25) was the chemistry structural modifications of Paeoniflorin (Pae). CP-25 inhibited B cells proliferation stimulated by B cell activating factor belonging to the TNF family (BAFF) or Tumor necrosis factor alpha (TNF-alpha). CP-25, Rituximab and Et...